MAX Chat
Santen Pharmaceutical Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
20.49 | 72.5 | -71.75% | 34.43 | -40.5% |
| P/S |
|
1.81 | 89.6 | -97.98% |
|
|
| P/BV |
|
1.79 | 69.35 | -97.42% |
|
|
| P/FCF |
|
9.13 | 62.17 | -85.32% |
|
|
| Ev/Ebitda |
|
8.61 | 28.83 | -70.12% |
|
|
| Ev/S |
|
1.61 | 80.92 | -98.01% |
|
|
| Ev/FCF |
|
7.85 | 26.69 | -70.59% |
|
|
| E/P |
|
0.0471 | 0.0253 | 86.03% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
6/10
|
18.7 | -141.33 | -113.23% | 15.06 | +24.17% |
| ROE |
|
8.88 | 1.54 | 475.72% |
|
|
| ROA |
|
6.22 | 0.9718 | 539.87% |
|
|
| ROIC |
|
11.36 | 8.38 | 35.48% |
|
|
| ROS |
|
8.82 | -178.64 | -104.94% |
|
|
| ROCE |
|
12.54 | -1.67 | -850.17% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
9/10
|
0.6227 | 4.49 | -86.14% | 0.9537 | -34.7% |
| Nеt Debt/Ebitda |
|
-1.05 | 15.09 | -106.97% |
|
|
| Debt/Ratio |
|
0.0807 | 0.1504 | -46.34% |
|
|
| Debt/Equity |
|
0.4268 | 1.11 | -61.68% |
|
|
| Debt/Net Income |
|
1.32 | -1.56 | -184.73% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
5.25/10
|
2.1 | 1.76 | 19.52% | 2.87 | -26.77% |
| Number of years of dividend growth |
|
3 | 1.74 | 72.41% | ||
| DSI |
|
0.9286 | 0.744 | 24.81% |
|
|
| Average dividend growth |
|
6.2 | -31.89 | -119.44% |
|
|
| Average percentage for 5 years |
|
2.87 | 16.98 | -83.11% |
|
|
| Average percentage for payments |
|
60.49 | 29.47 | 105.24% |
|
|
| Difference from average difference in sector |
|
0.343 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
20.19 | 168.81 | -88.04% | ||
| Growth impulse Ebitda in 5 years |
|
124.42 | 397.04 | -68.66% | ||
| Growth impulse Net Income in 5 years |
|
430.7 | 292.63 | 47.18% | ||
| Growth impulse FCF in 5 years |
|
261.77 | 355.53 | -26.37% | ||
| Growth impulse EPS in 5 years |
|
507.58 | 278.21 | 82.44% |
IP Score
7.45/10
